Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor
about
Atypical IκB proteins - nuclear modulators of NF-κB signalingRegulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesA mammalian factor that binds telomeric TTAGGG repeats in vitroI kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA bindingPurification of nuclear proteins from human HeLa cells that bind specifically to the unstable tandem repeat (CGG)n in the human FMR1 geneTwo genes encode factors with NF-kappa B- and H2TF1-like DNA-binding propertiesPurification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 geneSubcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBFCoupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activationCloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alphaA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationDimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleusA human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingersDNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding propertiesXAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivationTrans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase CI kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motifReactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa BHIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox stateHemoglobin switching in man and chicken is mediated by a heteromeric complex between the ubiquitous transcription factor CP2 and a developmentally specific proteinInterleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequenceThe glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domainBoth N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motifImpaired B cell development and function in the absence of IkappaBNSCyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokinesERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progressionNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeThe RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoproteinI kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domainSpecific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcriptionTranscription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expressionRole of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa BTetracycline-reversible silencing of eukaryotic promotersRegulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene productsThe yeast RNA1 gene product necessary for RNA processing is located in the cytosol and apparently excluded from the nucleusInterferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factorsInducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaBThe proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids
P2860
Q21245512-4A250CE2-4462-4A69-B712-B1542259A1D5Q21296830-EF75554A-D5E7-41EA-9134-022F0BD140BCQ24293724-E1401019-ED34-4435-9763-111379095C90Q24307786-18EC71B6-AC7F-4673-AEFB-B05EB796087AQ24310425-BB1E790B-E2F2-4226-A508-7836921BB6C9Q24311660-06381879-9642-4E61-9AB9-34CC09DC9240Q24312701-C7649A38-0B7B-4AEB-A4DA-4F4DBC00801CQ24314024-92B6D39B-BF96-44ED-B311-48CF3C7B6C4FQ24316905-F7F3E5BA-6DFC-46D3-AD8E-70656A98D95EQ24318577-3FADF28D-FA55-4424-BC19-8A2BFAE71777Q24320246-30385EB0-89E8-4C15-9F5B-2355964B70C9Q24321796-2D6EA899-6836-4BAB-8FEE-3E1E0A019A5DQ24337591-6E4DC74F-9149-4710-98DE-F16CA2E152E5Q24338438-87FAE184-C0FE-499F-A237-445C48219681Q24522560-707E8961-2CC9-4974-B1C3-946F5DE87278Q24544043-C2076192-2CD2-4E03-BE09-8520F60BB175Q24556556-41B975B0-AFCE-4231-8FED-EBF23E26DA32Q24561403-F720D178-6DA2-4A45-B0EA-7B021B280315Q24564855-24C04597-24DA-4527-BF18-FED566A498CCQ24568234-4DDB2F1B-882E-4CED-9427-316846CAB4A6Q24568360-E4E8E7E6-6648-4C17-BE4F-669A1B2A3AADQ24568375-F885EB9E-A367-4FCF-9F42-CEA612EDE770Q24598724-C50F5595-0361-4DCB-A463-D22CF06B9C41Q24600925-8958F618-C727-4DF2-B9A8-AB8007BEFFE7Q24606830-E375CE64-2748-4923-AB9A-78ED6A61BBE4Q24625466-691DABB0-1988-4D4A-8C98-FDA8C7F5CAD2Q24629510-18D3BC4C-B445-4DA9-86B5-467810917BFDQ24629604-801D9047-8B96-438F-9486-A911E65E4DF0Q24629772-C0CB6E87-B10A-481E-BF61-CB0B12AC4EFEQ24630135-9A52F782-699B-48D8-94A3-0F94E25712D1Q24643936-78FDAF4A-B1E8-490F-8EB8-9C2D486B1799Q24645001-07B3F365-EE8C-4E3C-A71E-0CCA3D8966EDQ24647749-E6228F42-D8A6-4471-8B31-B259C95CFE9BQ24648375-5C125144-BA65-4970-BC5E-8108038BA1F2Q24652702-C015AA8F-C26A-43DE-9F44-9025C824EA7AQ24655654-D5CF6036-A5A3-400F-B8F3-3B93DA767B9BQ24678911-225F339A-4205-4E10-9528-1C58095C656DQ24682160-DB32AF0B-C506-456B-9439-7CD8604FAA84Q24682171-805084A1-59A1-4188-8F41-B6E2092DF89BQ24792397-13C3B28D-8C81-48AE-A47B-B88A0FC0EE04
P2860
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor
description
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1988
@ast
im April 1988 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1988/04/22)
@sk
vědecký článek publikovaný v roce 1988
@cs
wetenschappelijk artikel (gepubliceerd op 1988/04/22)
@nl
наукова стаття, опублікована у квітні 1988
@uk
مقالة علمية (نشرت في 22-4-1988)
@ar
name
Activation of DNA-binding acti ...... F-kappa B transcription factor
@ast
Activation of DNA-binding acti ...... F-kappa B transcription factor
@en
Activation of DNA-binding acti ...... F-kappa B transcription factor
@nl
type
label
Activation of DNA-binding acti ...... F-kappa B transcription factor
@ast
Activation of DNA-binding acti ...... F-kappa B transcription factor
@en
Activation of DNA-binding acti ...... F-kappa B transcription factor
@nl
prefLabel
Activation of DNA-binding acti ...... F-kappa B transcription factor
@ast
Activation of DNA-binding acti ...... F-kappa B transcription factor
@en
Activation of DNA-binding acti ...... F-kappa B transcription factor
@nl
P3181
P1433
P1476
Activation of DNA-binding acti ...... F-kappa B transcription factor
@en
P2093
D. Baltimore
P. A. Baeuerle
P304
P3181
P356
10.1016/0092-8674(88)90382-0
P407
P577
1988-04-22T00:00:00Z